Sfoglia per Autore
PROTEOMIC EVALUATION OF CORE BIOPSY SPECIMENS FROM BREAST LESIONS
2004-01-01 Bisca, A.; D'Ambrosio, C.; Scaloni, A.; Puglisi, Fabio; Aprile, G.; Piga, Andrea; Zuiani, Chiara; Bazzocchi, Massimo; DI LORETO, Carla; Paron, I.; Tell, Gianluca; Damante, Giuseppe
LOCALLY ADVANCED BREAST CANCER: COMPARISON OF MAMMOGRAPHY, SONOGRAPHY AND MR IMAGING IN EVALUATION OF RESIDUAL DISEASE IN WOMEN RECEIVING NEOADJUVANT CHEMOTHERAPY
2004-01-01 Londero, V.; Bazzocchi, Massimo; DEL FRATE, Chiara; Puglisi, Fabio; DI LORETO, Carla; Francescutti, G.; Zuiani, Chiara
What is the effect of systemic anticancer treatment on cognitive function?
2004-01-01 Minisini, Alessandro Marco; Atalay, G; Bottomley, A; Puglisi, Fabio; Piccart, M; Biganzoli, L.
Baseline staging tests after a new diagnosis of breast cancer: further evidence of their limited indications
2005-01-01 Puglisi, Fabio; Follador, A; Minisini, Am; Cardellino, Gg; Russo, S; Andreetta, C; DI TERLIZZI, S; Piga, Andrea
Shrinking the tumor, shrinking the patient sample size: the early disclosure dilemma
2005-01-01 Puglisi, Fabio; De Azambuja, E; De Castro Jr, G; Demonty, G.
Topoisomerase II and APE/REF-1 are associated with pathologic response to primary anthracycline-based chemotherapy for breast cancer.
2005-01-01 Artico, D; DI LORETO, Carla; Mansutti, M; Minisini, Alessandro Marco; Piga, Andrea; Pizzolitto, S; Puglisi, Fabio
Trastuzumab and breast cancer. Are we just beyond the prologue of a fascinating story?
2005-01-01 Puglisi, Fabio; Piccart, M.
Proliferative high-risk lesions of the breast: contribution and limits of US-guided core biopsy
2005-01-01 Zuiani, Chiara; Londero, Viviana; Bestagno, Alexia; Puglisi, Fabio; Bazzocchi, Massimo; DI LORETO, Carla
PTEN and Egr-1 expression in thyroid proliferative lesions
2005-01-01 DI LORETO, Carla; Tell, Gianluca; Pestrin, M.; Pandolfi, M.; Damante, Giuseppe; Puglisi, Fabio
HER2 (neu) and trastuzumab (Herceptin®) - Paradigm of a targeted therapy
2006-01-01 Cufer, T; Puglisi, Fabio; Dal Lago, L; Demonty, G; Piccart Gebhart, Mj
Highlights from the 42nd annual meeting of the American Society of Clinical Oncology Atlanta, GA, USA, 2-6 June 2006
2006-01-01 Puglisi, Fabio; Andreetta, C; Fasola, G.
Multicenter phase II study of trastuzumab in combination with epirubicin and docetaxel as first-line treatment for HER2-overexpressing metastatic breast cancer.
2006-01-01 Bighin, C; Cappuzzo, F; DEL MASTRO, L; Durando, A; Lambiase, A; Monfardini, S; Nicoletto, O; Olmeo, N; Puglisi, Fabio; Venturini, M.
First-line treatment of metastatic breast cancer: available evidence and current recommendations
2006-01-01 Puglisi, Fabio; Cardoso, F; Lebrun, F; Piccart, M.
Dramatic tumour response to pemetrexed single-agent in an elderly patient with malignant peritoneal mesothelioma: a case report
2006-01-01 Fasola, G; Puglisi, Fabio; Follador, A; Aita, M; Di Terlizzi, S; Belvedere, O.
HEX expression and localization in normal mammary gland and breast carcinoma
2006-01-01 Puppin, C; Puglisi, Fabio; Pellizzari, L; Manfioletti, G; Pestrin, M; Pandolfi, M; Piga, Andrea; DI LORETO, Carla; Damante, Giuseppe
Angiogenesis and cancer: A cross-talk between basic science and clinical trials (the "do ut des" paradigm).
2006-01-01 Awada, A; DE AZAMBUJA, E; DE CASTRO, Jg; EL SAGHIR, Ns; Puglisi, Fabio
Sonographic criteria for differentiation of benign and malignant solid breast lesions: size is of value
2006-01-01 DEL FRATE, Chiara; Bestagno, Alexia; Cerniato, Roberta; Soldano, Franca; Isola, Miriam; Puglisi, Fabio; Bazzocchi, Massimo
Bone Scan for Baseline Staging in Invasive Breast Cancer at the Time of Primary Presentation
2007-01-01 Puglisi, Fabio; Andreetta, C; Fasola, G; Cattaruzzi, E; Geatti, O.
Anthracyclines and taxanes induce the upregulation of thymidine phosphorylase in breast cancer cells
2007-01-01 Puglisi, Fabio; Andreetta, C; Valent, F; Minisini, Am; Rijavec, E; Russo, S; Mansutti, M; Cardellino, G; Pizzolitto, S; DI LORETO, Carla
Markers of the uPA system and common prognostic factors in breast cancer
2007-01-01 Minisini, Am; Fabbro, D; DI LORETO, Carla; Pestrin, M; Russo, S; Cardellino, Gg; Andreetta, C; Damante, Giuseppe; Puglisi, Fabio
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
PROTEOMIC EVALUATION OF CORE BIOPSY SPECIMENS FROM BREAST LESIONS | 1-gen-2004 | Bisca, A.; D'Ambrosio, C.; Scaloni, A.; Puglisi, Fabio; Aprile, G.; Piga, Andrea; Zuiani, Chiara; Bazzocchi, Massimo; DI LORETO, Carla; Paron, I.; Tell, Gianluca; Damante, Giuseppe | |
LOCALLY ADVANCED BREAST CANCER: COMPARISON OF MAMMOGRAPHY, SONOGRAPHY AND MR IMAGING IN EVALUATION OF RESIDUAL DISEASE IN WOMEN RECEIVING NEOADJUVANT CHEMOTHERAPY | 1-gen-2004 | Londero, V.; Bazzocchi, Massimo; DEL FRATE, Chiara; Puglisi, Fabio; DI LORETO, Carla; Francescutti, G.; Zuiani, Chiara | |
What is the effect of systemic anticancer treatment on cognitive function? | 1-gen-2004 | Minisini, Alessandro Marco; Atalay, G; Bottomley, A; Puglisi, Fabio; Piccart, M; Biganzoli, L. | |
Baseline staging tests after a new diagnosis of breast cancer: further evidence of their limited indications | 1-gen-2005 | Puglisi, Fabio; Follador, A; Minisini, Am; Cardellino, Gg; Russo, S; Andreetta, C; DI TERLIZZI, S; Piga, Andrea | |
Shrinking the tumor, shrinking the patient sample size: the early disclosure dilemma | 1-gen-2005 | Puglisi, Fabio; De Azambuja, E; De Castro Jr, G; Demonty, G. | |
Topoisomerase II and APE/REF-1 are associated with pathologic response to primary anthracycline-based chemotherapy for breast cancer. | 1-gen-2005 | Artico, D; DI LORETO, Carla; Mansutti, M; Minisini, Alessandro Marco; Piga, Andrea; Pizzolitto, S; Puglisi, Fabio | |
Trastuzumab and breast cancer. Are we just beyond the prologue of a fascinating story? | 1-gen-2005 | Puglisi, Fabio; Piccart, M. | |
Proliferative high-risk lesions of the breast: contribution and limits of US-guided core biopsy | 1-gen-2005 | Zuiani, Chiara; Londero, Viviana; Bestagno, Alexia; Puglisi, Fabio; Bazzocchi, Massimo; DI LORETO, Carla | |
PTEN and Egr-1 expression in thyroid proliferative lesions | 1-gen-2005 | DI LORETO, Carla; Tell, Gianluca; Pestrin, M.; Pandolfi, M.; Damante, Giuseppe; Puglisi, Fabio | |
HER2 (neu) and trastuzumab (Herceptin®) - Paradigm of a targeted therapy | 1-gen-2006 | Cufer, T; Puglisi, Fabio; Dal Lago, L; Demonty, G; Piccart Gebhart, Mj | |
Highlights from the 42nd annual meeting of the American Society of Clinical Oncology Atlanta, GA, USA, 2-6 June 2006 | 1-gen-2006 | Puglisi, Fabio; Andreetta, C; Fasola, G. | |
Multicenter phase II study of trastuzumab in combination with epirubicin and docetaxel as first-line treatment for HER2-overexpressing metastatic breast cancer. | 1-gen-2006 | Bighin, C; Cappuzzo, F; DEL MASTRO, L; Durando, A; Lambiase, A; Monfardini, S; Nicoletto, O; Olmeo, N; Puglisi, Fabio; Venturini, M. | |
First-line treatment of metastatic breast cancer: available evidence and current recommendations | 1-gen-2006 | Puglisi, Fabio; Cardoso, F; Lebrun, F; Piccart, M. | |
Dramatic tumour response to pemetrexed single-agent in an elderly patient with malignant peritoneal mesothelioma: a case report | 1-gen-2006 | Fasola, G; Puglisi, Fabio; Follador, A; Aita, M; Di Terlizzi, S; Belvedere, O. | |
HEX expression and localization in normal mammary gland and breast carcinoma | 1-gen-2006 | Puppin, C; Puglisi, Fabio; Pellizzari, L; Manfioletti, G; Pestrin, M; Pandolfi, M; Piga, Andrea; DI LORETO, Carla; Damante, Giuseppe | |
Angiogenesis and cancer: A cross-talk between basic science and clinical trials (the "do ut des" paradigm). | 1-gen-2006 | Awada, A; DE AZAMBUJA, E; DE CASTRO, Jg; EL SAGHIR, Ns; Puglisi, Fabio | |
Sonographic criteria for differentiation of benign and malignant solid breast lesions: size is of value | 1-gen-2006 | DEL FRATE, Chiara; Bestagno, Alexia; Cerniato, Roberta; Soldano, Franca; Isola, Miriam; Puglisi, Fabio; Bazzocchi, Massimo | |
Bone Scan for Baseline Staging in Invasive Breast Cancer at the Time of Primary Presentation | 1-gen-2007 | Puglisi, Fabio; Andreetta, C; Fasola, G; Cattaruzzi, E; Geatti, O. | |
Anthracyclines and taxanes induce the upregulation of thymidine phosphorylase in breast cancer cells | 1-gen-2007 | Puglisi, Fabio; Andreetta, C; Valent, F; Minisini, Am; Rijavec, E; Russo, S; Mansutti, M; Cardellino, G; Pizzolitto, S; DI LORETO, Carla | |
Markers of the uPA system and common prognostic factors in breast cancer | 1-gen-2007 | Minisini, Am; Fabbro, D; DI LORETO, Carla; Pestrin, M; Russo, S; Cardellino, Gg; Andreetta, C; Damante, Giuseppe; Puglisi, Fabio |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile